San Francisco Mayor Ed Lee has just announced the city’s open data strategic plan, which aims to “broaden the focus of open data from simply publishing to making it available in a manner that fosters better use of the data.” This plan came five months after the appointment of Joy Bonaguro as the city’s first Chief Data Officer (CDO).
Last week, Durata Therapeutics, Inc. (Nasdaq:DRTX) announced that DALVANCE (dalbavancin) for injection is now available for use to treat adult patients with acute bacterial skin and skin structure infections (ABSSSI). DALVANCE was approved by the U.S. Food and Drug Administration (FDA) on May 23, 2014 and was the first drug approved as a Qualified Infectious Disease Product (QIDP). Durata began shipping DALVANCE to its distributors earlier this week.
According to a report that Express Scripts released state legislatures will need to find billions in their budgets to purchase costly new hepatitis C therapy, according to a new state-by-state analysis released today by Express Scripts (NASDAQ: ESRX). But their report is near sighted only looking at the immediate costs of the prescription, instead of the longterm cost stagings this therapy can provide.
(Reuters) – Illinois children and adults with epilepsy will soon be allowed to use marijuana to ease their symptoms under a law signed on Sunday by Democratic Governor Pat Quinn, the latest in a series of measures loosening restrictions on cannabis by U.S. states.
A pair of California healthcare companies are teaming up to outfit a suite of ambulances and mobile medical teams with Google Glass, allowing first responders to collaborate with hospitals while en route with emergency patients.
IBM said it has created a system to predict the sources of contaminated foods after outbreaks of food-borne illnesses. The company believes it can help grocers, distributors, and public health officials accelerate the investigation of outbreaks of food poisoning using novel computer algorithms, visualization, and statistical techniques.